Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 9/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27991213 | 0.87 | TRPA1 (0.52) | TRPA1LMNAHKDC1TAAR1CYP2D6 | |
| SCHEMBL22009966 | 0.85 | HKDC1 (0.52) | TRPA1LMNAHKDC1TAAR1AOC3 | |
| SCHEMBL28312241 | 0.83 | TRPA1 (0.52) | TRPA1LMNAHKDC1TAAR1CYP2D6 | |
| SCHEMBL111159 | 0.83 | TRPA1 (0.50) | TRPA1LMNATAAR1AOC3CYP2D6 | |
| SCHEMBL14593318 | 0.81 | LMNA (0.50) | TRPA1LMNAHKDC1TAAR1AOC3 | |
| SCHEMBL14593319 | 0.81 | LMNA (0.50) | TRPA1LMNAHKDC1TAAR1AOC3 | |
| SCHEMBL873143 | 0.80 | TAAR1 (0.61) | TRPA1LMNAHKDC1TAAR1CYP2D6 | |
| SCHEMBL759880 | 0.80 | TAAR1 (0.61) | TRPA1LMNAHKDC1TAAR1CYP2D6 | |
| SCHEMBL9908239 | 0.80 | TAAR1 (0.61) | TRPA1LMNAHKDC1TAAR1CYP2D6 | |
| SCHEMBL11744344 | 0.79 | SLC6A2 (0.50) | TRPA1LMNAHKDC1TAAR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20190300526-A1 | PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS | CHEMOCENTRYX, INC. | 2019-10-03 | — | — | US | disclosed |
| EP-2900223-B1 | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | MERCK SHARP & DOHME (US) | 2017-10-25 | — | — | EP | disclosed |
| US-7498126-B2 | Photoacid generators, chemically amplified resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-7494760-B2 | Photoacid generators, chemically amplified resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-20080305411-A1 | PHOTOMASK BLANK, RESIST PATTERN FORMING PROCESS, AND PHOTOMASK PREPARATION PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300526-A1 | PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS | C5AR2, C5AR1, C3AR1 | TRPA1 1123/4885LMNA 2103/4885HKDC1 3379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.